ZA921575B - Pharmaceuticals - Google Patents

Pharmaceuticals

Info

Publication number
ZA921575B
ZA921575B ZA921575A ZA921575A ZA921575B ZA 921575 B ZA921575 B ZA 921575B ZA 921575 A ZA921575 A ZA 921575A ZA 921575 A ZA921575 A ZA 921575A ZA 921575 B ZA921575 B ZA 921575B
Authority
ZA
South Africa
Prior art keywords
pharmaceuticals
Prior art date
Application number
ZA921575A
Inventor
Giuseppe Giardina
Giardina Giuseppe
Geoffrey Douglas Clarke
Douglas Clarke Geoffrey
Original Assignee
Zambeletti Spa L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambeletti Spa L filed Critical Zambeletti Spa L
Publication of ZA921575B publication Critical patent/ZA921575B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA921575A 1991-03-05 1992-03-03 Pharmaceuticals ZA921575B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919104656A GB9104656D0 (en) 1991-03-05 1991-03-05 Pharmaceuticals

Publications (1)

Publication Number Publication Date
ZA921575B true ZA921575B (en) 1992-12-30

Family

ID=10691041

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA921575A ZA921575B (en) 1991-03-05 1992-03-03 Pharmaceuticals

Country Status (8)

Country Link
EP (1) EP0574477A1 (en)
CA (1) CA2105589A1 (en)
GB (1) GB9104656D0 (en)
IE (1) IE920679A1 (en)
MX (1) MX9200948A (en)
PT (1) PT100188A (en)
WO (1) WO1992015304A2 (en)
ZA (1) ZA921575B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8926560D0 (en) * 1989-11-24 1990-01-17 Zambeletti Spa L Pharmaceuticals
CA2081351A1 (en) * 1990-04-28 1991-10-29 Vittorio Vecchietti 1-(2h-1-oxo-3, 4-dihydronaphtyl-6) -acetyl-piperidines, process for their preparation and therapeutic use
ATE475640T1 (en) 2004-03-12 2010-08-15 Lilly Co Eli ANTAGONISTS OF THE OPIOID RECEPTOR
US7615556B2 (en) 2006-01-27 2009-11-10 Bristol-Myers Squibb Company Piperazinyl derivatives as modulators of chemokine receptor activity
US7601844B2 (en) 2006-01-27 2009-10-13 Bristol-Myers Squibb Company Piperidinyl derivatives as modulators of chemokine receptor activity
TWI433838B (en) 2008-06-25 2014-04-11 必治妥美雅史谷比公司 Piperidinyl derivative as a modulator of chemokine receptor activity
HUE028983T2 (en) 2010-05-06 2017-01-30 Vertex Pharma Heterocyclic chromene-spirocyclic piperidine amides as modulators of ion channels
US8642622B2 (en) 2010-06-16 2014-02-04 Bristol-Myers Squibb Company Piperidinyl compound as a modulator of chemokine receptor activity
EP3056495A1 (en) 2011-02-02 2016-08-17 Vertex Pharmaceuticals Inc. Pyrrolopyrazine-spirocyclic piperidine amides as modulators of ion channels
US10385070B2 (en) 2011-02-18 2019-08-20 Vertex Pharmaceuticals Incorporated Chroman-spirocyclic piperidine amides as modulators of ion channels
WO2012125613A1 (en) 2011-03-14 2012-09-20 Vertex Pharmaceuticals Incorporated Morpholine-spirocyclic piperidine amides as modulators of ion channels

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01308229A (en) * 1988-02-23 1989-12-12 Glaxo Group Ltd Heterocyclic derivative
GB8804104D0 (en) * 1988-02-23 1988-03-23 Glaxo Group Ltd Chemical compounds
EP0330467A1 (en) * 1988-02-23 1989-08-30 Glaxo Group Limited Heterocyclic compounds
GB8813714D0 (en) * 1988-06-09 1988-07-13 Glaxo Group Ltd Chemical compounds
DE68924751T2 (en) * 1988-09-26 1996-04-11 Smithkline Beecham Farma Azacyclic compounds useful as medicines.

Also Published As

Publication number Publication date
WO1992015304A3 (en) 1993-06-24
MX9200948A (en) 1992-11-01
IE920679A1 (en) 1992-09-09
PT100188A (en) 1993-05-31
GB9104656D0 (en) 1991-04-17
WO1992015304A2 (en) 1992-09-17
CA2105589A1 (en) 1992-09-06
EP0574477A1 (en) 1993-12-22

Similar Documents

Publication Publication Date Title
GB9103839D0 (en) Pharmaceuticals
GB9121835D0 (en) Pharmaceuticals
GB9104656D0 (en) Pharmaceuticals
ZA919756B (en) Pharmaceuticals
ZA92343B (en) Pharmaceuticals
GB9121170D0 (en) Pharmaceuticals
AP9200422A0 (en) Pharmaceuticals
GB9107896D0 (en) Pharmaceuticals
GB9102656D0 (en) Pharmaceuticals
GB9117646D0 (en) Pharmaceuticals
GB9114171D0 (en) Pharmaceuticals
IL99080A0 (en) Pharmaceuticals
GB9127202D0 (en) Pharmaceuticals
GB9127185D0 (en) Pharmaceuticals
GB9110990D0 (en) Pharmaceuticals
GB9110774D0 (en) Pharmaceuticals
GB9116879D0 (en) Pharmaceuticals
GB9120390D0 (en) Pharmaceuticals
GB9126896D0 (en) Pharmaceuticals
GB9103696D0 (en) Pharmaceuticals
GB9124754D0 (en) Pharmaceuticals
GB9116891D0 (en) Pharmaceuticals
GB9127184D0 (en) Pharmaceuticals
GB9100580D0 (en) Pharmaceuticals
GB9100370D0 (en) Pharmaceuticals